JP2024527939A5 - - Google Patents

Info

Publication number
JP2024527939A5
JP2024527939A5 JP2024504833A JP2024504833A JP2024527939A5 JP 2024527939 A5 JP2024527939 A5 JP 2024527939A5 JP 2024504833 A JP2024504833 A JP 2024504833A JP 2024504833 A JP2024504833 A JP 2024504833A JP 2024527939 A5 JP2024527939 A5 JP 2024527939A5
Authority
JP
Japan
Prior art keywords
composition
glycero
lipid nanoparticle
nanoparticle composition
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527939A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038151 external-priority patent/WO2023009421A1/en
Publication of JP2024527939A publication Critical patent/JP2024527939A/ja
Publication of JP2024527939A5 publication Critical patent/JP2024527939A5/ja
Pending legal-status Critical Current

Links

JP2024504833A 2021-07-26 2022-07-25 脂質ナノ粒子組成物を調製するためのプロセス Pending JP2024527939A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163225815P 2021-07-26 2021-07-26
US63/225,815 2021-07-26
PCT/US2022/038151 WO2023009421A1 (en) 2021-07-26 2022-07-25 Processes for preparing lipid nanoparticle compositions

Publications (2)

Publication Number Publication Date
JP2024527939A JP2024527939A (ja) 2024-07-26
JP2024527939A5 true JP2024527939A5 (cg-RX-API-DMAC7.html) 2025-08-04

Family

ID=82899410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504833A Pending JP2024527939A (ja) 2021-07-26 2022-07-25 脂質ナノ粒子組成物を調製するためのプロセス

Country Status (6)

Country Link
US (1) US20240335393A1 (cg-RX-API-DMAC7.html)
EP (1) EP4376814A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527939A (cg-RX-API-DMAC7.html)
CN (1) CN118019527A (cg-RX-API-DMAC7.html)
TW (1) TW202320736A (cg-RX-API-DMAC7.html)
WO (1) WO2023009421A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
WO2025103414A1 (zh) * 2023-11-14 2025-05-22 上海瑞宏迪医药有限公司 一种脂质纳米粒的制备方法和应用
WO2025214340A1 (zh) * 2024-04-08 2025-10-16 苏州艾博生物科技有限公司 脂质纳米颗粒制剂及其制备方法
GB2702140A (en) 2024-10-10 2026-06-03 Apoha Ltd Method and apparatus
WO2026153419A1 (en) * 2025-01-16 2026-07-23 Suzhou Abogen Biosciences Co., Ltd. Lipid nanoparticle compositions and processes of preparing the same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
WO2006044660A2 (en) * 2004-10-14 2006-04-27 Vanderbilt University Functionalized solid lipid nanoparticles and methods of making and using same
RU2573409C2 (ru) * 2009-11-04 2016-01-20 Дзе Юниверсити Оф Бритиш Коламбиа Содержащие нуклеиновые кислоты липидные частицы и относящиеся к ним способы
EP2857499A1 (en) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9999673B2 (en) 2011-01-11 2018-06-19 Alnylam Pharmaceuticals, Inc. PEGylated lipids and their use for drug delivery
WO2013086322A1 (en) * 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
WO2014093924A1 (en) 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
WO2014164253A1 (en) 2013-03-09 2014-10-09 Moderna Therapeutics, Inc. Heterologous untranslated regions for mrna
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
WO2017031232A1 (en) * 2015-08-17 2017-02-23 Modernatx, Inc. Methods for preparing particles and related compositions
HRP20220156T1 (hr) * 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
US12076439B2 (en) * 2018-05-24 2024-09-03 Translate Bio, Inc. Thioester cationic lipids
DK3864163T3 (da) * 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
EP4031524A1 (en) * 2019-09-19 2022-07-27 ModernaTX, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents

Similar Documents

Publication Publication Date Title
JP2024527940A5 (cg-RX-API-DMAC7.html)
JP2023513043A5 (cg-RX-API-DMAC7.html)
JP2022548304A5 (cg-RX-API-DMAC7.html)
Kulkarni et al. On the role of helper lipids in lipid nanoparticle formulations of siRNA
JP2022548312A5 (cg-RX-API-DMAC7.html)
JP2022502451A5 (cg-RX-API-DMAC7.html)
JP2023543963A5 (cg-RX-API-DMAC7.html)
JP2023538260A5 (cg-RX-API-DMAC7.html)
JP2022549253A5 (cg-RX-API-DMAC7.html)
EP2558074B1 (en) Preparation of lipid nanoparticles
JP2020510072A5 (cg-RX-API-DMAC7.html)
JP5831588B2 (ja) リポソームの製造方法
JP2024542099A5 (cg-RX-API-DMAC7.html)
JP2021511376A (ja) 脂質ナノ粒子
JP4857392B2 (ja) リポソームの製造方法ならびにコレステロール溶解方法
CN103989633A (zh) 制造脂质体的系统和方法
RU2660585C2 (ru) Фармацевтическая композиция для уменьшения осложнений применения стероидных препаратов при лечении офтальмологических заболеваний
CN103002876A (zh) 亲脂性化合物的改进脂质体制剂
JP2025523587A (ja) 核酸送達のための局所送達用カチオン性コレステロールを使用した脂質ナノ粒子
WO2025218536A1 (zh) 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用
JP2008512446A (ja) グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
JP2024545584A5 (cg-RX-API-DMAC7.html)
US12582610B2 (en) Lipid-polymer compositions and methods of use
WO2024046448A1 (en) Lyophilized formulations and liquid formulations of lipid nanoparticles
CN115708818B (zh) 一种用于雾化吸入脂质纳米粒的通用型处方